Jing Lin

Jing Lin

Auto-generated profile, based on publicly available information

Jing Lin

Department of Obstetrics and Gynaecology, Prince of Wales Hospital The Chinese University of Hong Kong Shatin Hong Kong SAR China

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2026 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Open access
PDF file
YCYunyu Constance Chen
Yunyu Constance Chen
YLY. Liao
Y. Liao
QZQ. Zhang
Q. Zhang
MMM. Machida
M. Machida
KUK. Uenishi
K. Uenishi
LPLiona C. Poon
Liona C. Poon
Objectives: To evaluate the normal development of the fetal corpus callosum (CC) between 18 and 32 weeks' gestation using three‐dimensional (3D) transvaginal neurosonography and to assess the effect of volume contrast imaging (VCI) on the measurement of fetal CC biometry. Methods: This study included two cohorts of women with a singleton pregnancy: a prospective cohort attending the research clinic at Prince of Wales Hospital in Hong Kong SAR, China, between April 2019 and February 2025, at which 3D fetal brain volumes were acquired prospectively, and a retrospective cohort attending CRIFM Prenatal Medical Clinic in Osaka, Japan, between December 2018 and March 2025, from which archived 3D fetal brain volume datasets were retrieved. In both cohorts, 3D fetal brain volume data of the CC were acquired using transvaginal neurosonography between 18 and 32 weeks' gestation using the same acquisition protocol. Inclusion criteria were appropriately grown fetuses at 18 + 0 to 32 + 6 weeks' gestation, without suspected structural or chromosomal defects. In the midsagittal plane, using 3D volume multiplanar imaging, the CC length and total area were obtained and regional thickness at the genu, body and splenium were measured following a modified Garel's method. Additionally, the areas of five vertical CC segments defined by arithmetic fractions of the CC length following Witelson's classification (anterior one‐third, anterior midbody, posterior midbody, isthmus and splenium) were obtained. All fetal biometric measurements were performed using non‐VCI and VCI modes. Measurements obtained using non‐VCI and VCI modes were compared using the paired t ‐test. Generalized Additive Models for Location, Scale and Shape (GAMLSS) were used to explore the relationship between all biometric measurements of the fetal CC and gestational age. The final models were used to derive percentiles and construct reference curves. Intra‐ and interobserver variability were assessed using 30 randomly selected cases. Results: A total of 956 fetuses at 18–32 weeks' gestation were included. Gestational age‐specific trajectories of fetal CC biometry were established, demonstrating distinct, non‐linear growth patterns in CC length, total area, genu, body and splenium thicknesses and the areas of five individual CC subdivisions from 18 to 32 weeks. Overall, the genu and body thicknesses increased sharply from 18 weeks to 23 weeks. Thereafter, genu thickness continued to increase gradually until 32 weeks, whereas body thickness plateaued before showing renewed growth at 31–32 weeks. The percentile curve for fetal CC total area demonstrated a steady increase from 18 to 32 weeks. Among the five subdivisions of the CC, the splenium demonstrated the most pronounced absolute area growth, reaching a median of approximately 0.40 cm 2 by 32 weeks, with markedly greater expansion than the midbody regions throughout the second to early third trimesters. Fetal CC biometric measurements were comparable between non‐VCI and VCI measurements. Overall, the biometric measurements demonstrated high reproducibility, with most showing good‐to‐excellent intra‐ and interobserver reliability, except for moderate interobserver reliability for genu and body thicknesses. Conclusions: We have characterized region‐specific non‐linear growth patterns in fetal CC development from 18 to 32 weeks, with posterior‐predominant area expansion most pronounced in the splenium. The clinical significance of regional CC measurements remains uncertain, and the presented trajectories should be regarded as descriptions of normal developmental patterns rather than as reference charts for isolated clinical decision‐making. Longitudinal studies incorporating postnatal neurodevelopmental assessment will be required to determine their prognostic value. © 2026 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

13 June 2025 in Clinical Radiology
Verified
Journal Article
Closed access
LCL. Chen
L. Chen
JLJ. Lin
J. Lin
RCR. Cui
R. Cui
SQS. Qin
S. Qin
YCY. Chen
Y. Chen
GLGuang-Jian Liu
Guang-Jian Liu

10 April 2026 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Open access
JLJ. Lin
J. Lin
XWX. Wang
X. Wang
YCY. Chen
Y. Chen
LNL. Nguyen‐Hoang
L. Nguyen‐Hoang
ATA. S. T. Tai
A. S. T. Tai
LPLiona C. Poon
Liona C. Poon
Objective: To evaluate maternal cardiac adaptation during pregnancy by comparing longitudinal hemodynamic profiles between women identified as high risk for preterm pre‐eclampsia (PE) who subsequently developed preterm PE, term PE or remained unaffected, as well as low‐risk women. Methods: This was a prospective longitudinal study of 1078 Chinese women with a singleton pregnancy who were enrolled in a first‐trimester screen‐and‐prevent program for preterm PE at the Prince of Wales Hospital, Hong Kong SAR, China, between January 2020 and June 2024. Participants were classified as high or low risk for preterm PE based on the Fetal Medicine Foundation first‐trimester combined test. Participants were followed up at 12 + 0 to 15 + 6 weeks' gestation, 20 + 0 to 24 + 6 weeks and 30 + 0 to 37 + 6 weeks to measure hemodynamic variables, including heart rate (HR), stroke volume (SV), cardiac output (CO), systemic vascular resistance (SVR) and mean arterial pressure (MAP). Participants were categorized into four groups according to risk status for preterm PE and subsequent development of PE: low risk who did not develop PE (Group 1, n = 407); high risk who did not develop PE (Group 2, n = 598); high risk who developed term PE (Group 3, n = 29); and high risk who developed preterm PE (Group 4, n = 44). Hemodynamic variables were log 10 transformed and analyzed using linear mixed‐effects models, adjusting for maternal characteristics and clinical visits. Estimated marginal means of log 10 ‐transformed values for hemodynamic variables were compared between the groups throughout pregnancy and at each clinical visit. Results: Compared with Group 1, all high‐risk groups exhibited lower SV and CO and higher SVR and MAP throughout pregnancy (all P < 0.05), while HR was significantly elevated in Group 2 ( P < 0.001). Compared with Group 2, Group 4 had lower HR, SV and CO and higher SVR and MAP throughout pregnancy (all P < 0.01). In contrast, Group 3 showed no significant differences in HR, SV, CO and SVR compared with Group 2 (all P > 0.05), although there was an increase in MAP from midgestation onwards ( P < 0.001). Compared with Group 3, Group 4 exhibited lower CO and higher SVR and MAP throughout pregnancy (all P < 0.05). Conclusions: Compared with low‐risk women who do not develop PE, high‐risk women with or without preterm or term PE exhibit distinct cardiac maladaptation profiles from early to late gestation. These findings offer insight into the different pathophysiological mechanisms underlying PE subtypes and should inform risk stratification. © 2026 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

4 July 2026 in American Journal of Obstetrics & Gynecology MFM
Verified
Journal Article
Open access
JLJing Lin
Jing Lin
YCYunyu Chen
Yunyu Chen
LPLiona C. Poon
Liona C. Poon
Hypertensive disorders of pregnancy (HDP) are a leading cause of maternal and perinatal morbidity and mortality. Pregnancy is increasingly viewed as a physiological "stress test" capable of revealing latent cardiovascular susceptibility in women predisposed to future cardiovascular disease (CVD). In HDP, this vulnerability becomes clinically evident as impaired cardiovascular adaptation during pregnancy. It remains uncertain whether women who develop both HDP and CVD share common pre-existing risk factors or whether HDP contribute directly to long-term cardiovascular impairment. In normotensive pregnancy, systemic vascular resistance declines, blood volume and cardiac output increase significantly, and the heart undergoes reversible structural remodeling. In contrast, HDP are characterized by abnormal placentation, angiogenic imbalance, endothelial dysfunction, disrupted maternal hemodynamic balance, and adverse cardiac remodeling. Importantly, these maladaptive cardiovascular changes may persist well beyond delivery, leading to prolonged ventricular dysfunction and chronic cardiovascular changes. This review focuses on the cardiovascular maladaptation in HDP and its long-term effects on affected women and their offspring, as well as targeted interventions to reduce the risk of HDP and subsequent CVD.

27 September 2026 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Open access
JLJ. Lin
J. Lin
LNL. Nguyen‐Hoang
L. Nguyen‐Hoang
LDL. T. Dinh
L. T. Dinh
RPR. K. Pooh
R. K. Pooh
Akihide OhkuchiAkihide Ohkuchi
Akihide Ohkuchi
FCForecast Collaborators
Forecast Collaborators
Objectives: To identify potential risk factors – among maternal factors, pre‐eclampsia (PE)‐specific biomarkers and estimated risks derived from the first‐trimester Fetal Medicine Foundation (FMF) triple test – that are associated with the subsequent development of preterm PE, and to evaluate predictors of any‐onset PE using time‐to‐event analysis, in high‐risk women receiving low‐dose aspirin prophylaxis. Methods: This was a secondary analysis of a multicenter stepped‐wedge cluster randomized trial, including 18 maternity/diagnostic units from 10 regions in Asia between August 2019 and February 2022. The study population comprised women with a singleton pregnancy identified as being at high risk for preterm PE (estimated risk ≥ 1:100) according to the first‐trimester FMF triple test, who subsequently received low‐dose aspirin prophylaxis. A locally estimated scatterplot smoothing (LOESS) curve was applied initially to explore the relationship between the incidence of preterm PE and the estimated risk. Based on the trend observed in the LOESS curve, participants were categorized into five estimated risk groups: 1:2 to 1:5, 1:6 to 1:10, 1:11 to 1:20, 1:21 to 1:50 and 1:51 to 1:100. Logistic and Cox regression analyses were performed to identify independent predictors of preterm PE and to evaluate the risk of delivery with PE, respectively. Results: Among 2919 high‐risk pregnant women receiving aspirin prophylaxis, 280 (9.6%) developed PE, including 107 (3.7%) who developed preterm PE. Chronic hypertension (adjusted odds ratio (aOR), 1.835 (95% CI, 1.070–3.146)), mean arterial pressure (MAP) multiples of the median (MoM) > 1.149 (aOR, 2.162 (95% CI, 1.434–3.261)) and higher estimated risk were associated with higher odds of preterm PE. Compared to women with an estimated risk of 1:51 to 1:100, those with estimated risks of 1:2 to 1:5, 1:6 to 1:10 and 1:11 to 1:20 had a 16‐fold (aOR, 15.845 (95% CI, 8.166–30.746)), eight‐fold (aOR, 7.674 (95% CI, 3.925–15.004)) and three‐fold (aOR, 3.454 (95% CI, 1.802–6.622)) higher odds of developing preterm PE, respectively, whereas no significant difference was observed in those with an estimated risk of 1:21 to 1:50 (aOR, 1.343 (95% CI, 0.722–2.499)). On Cox regression analysis, chronic hypertension was associated with a three‐fold higher risk of delivering with PE (adjusted hazard ratio (aHR), 2.979 (95% CI, 2.154–4.120)), while MAP MoM > 1.149 increased the risk by 66% (aHR, 1.659 (95% CI, 1.304–2.111)). Compared with the reference group (estimated risk of 1:51 to 1:100), the risk of delivering with PE increased progressively across estimated risk groups, with aHRs of 1.435 (95% CI, 1.051–1.959), 2.408 (95% CI, 1.653–3.508), 4.058 (95% CI, 2.658–6.197) and 7.053 (95% CI, 4.588–10.841) for the 1:21 to 1:50, 1:11 to 1:20, 1:6 to 1:10, and 1:2 to 1:5 estimated risk groups, respectively. Conclusions: Chronic hypertension, elevated MAP and higher estimated risk are associated with the earlier development of PE in women identified as high risk by the first‐trimester FMF triple test, despite low‐dose aspirin prophylaxis. Incorporating these factors into the risk stratification framework may improve the detection of residual risk in first‐trimester screening and prevention strategies, thereby supporting the development of more effective preventive measures. © 2026 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

28 September 2026 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Open access
YCYunyu Constance Chen
Yunyu Constance Chen
IWI. S. Wong
I. S. Wong
XCX. Chen
X. Chen
JLJ. Lin
J. Lin
JLJ. Liu
J. Liu
LPLiona C. Poon
Liona C. Poon
Objectives: To compare anthropometric and cardiovascular parameters at 6–12 weeks postpartum among women classified at first‐trimester screening as high risk for pre‐eclampsia (PE) who subsequently developed hypertensive disorders of pregnancy (HDP), those classified as high risk who did not develop HDP and those classified as low risk for PE, and, among high‐risk women, to evaluate the trajectory of these parameters from 6–12 weeks to 12 months postpartum according to the subsequent development of HDP. Methods: This was a prospective postpartum longitudinal study conducted at the Prince of Wales Hospital, Hong Kong Special Administrative Region, in which women underwent postpartum assessment between October 2022 and January 2025. Eligible participants were Chinese women in the postpartum period following a singleton pregnancy who had undergone first‐trimester PE screening at 11 + 0 to 13 + 6 weeks' gestation. Women were classified into three groups based on their first‐trimester screening result and subsequent pregnancy outcome: (1) women at high risk (≥ 1:100) for PE who subsequently developed HDP; (2) women at high risk for PE who did not develop HDP; and (3) low‐risk controls with a normotensive pregnancy. Participants were enrolled between 6 and 12 weeks postpartum for anthropometric and cardiovascular assessments, and these findings were compared among the groups. Subsequently, women at high risk for PE were examined longitudinally at 6 months and 12 months postpartum to assess changes in anthropometric and cardiovascular parameters. High‐risk women received lifestyle counseling at each visit. Linear mixed‐effects analysis was performed to compare the longitudinal changes in anthropometric and cardiovascular parameters over the postpartum period. Results: Overall, 201 women were included in the study, of whom 130 were at high risk for PE and did not develop HDP, 41 were at high risk for PE and developed HDP and 30 were low‐risk controls. At 6–12 weeks postpartum, high‐risk women with HDP exhibited a significantly higher mean arterial pressure, left ventricular (LV) mass index (MI), systemic vascular resistance, myocardial performance index and more impaired global longitudinal strain (GLS), along with lower mitral annular plane systolic excursion, compared with the low‐risk and high‐risk‐without‐HDP groups. Similar findings mostly persisted over the 12‐month postpartum period, even after adjusting for risk factors (all P < 0.05). From 6 to 12 weeks to 12 months postpartum, the high‐risk‐without‐HDP group showed a statistically significant declining trend in weight, waist circumference and waist‐to‐hip ratio, along with reduced weight gain from the first trimester to 12 months postpartum, whereas the high‐risk‐with‐HDP group showed no significant change during the same period. The high‐risk‐without‐HDP group exhibited a decreasing trend in LV‐MI and increasing trends in LV ejection fraction, GLS, left atrial emptying fraction and left atrial expansion index from 6–12 weeks to 6 months postpartum. Conversely, in the high‐risk‐with‐HDP group, these improvements only became apparent at 12 months postpartum (all P < 0.05). Conclusions: Women identified as being at high risk for PE at first‐trimester screening, particularly those who develop HDP, exhibit consistently suboptimal anthropometric and cardiovascular trajectories during the first year postpartum. The observed association between maternal risk factors and an unfavorable cardiovascular profile underscores the need to extend anthropometric and cardiovascular screening and implement personalized interventions beyond the standard 6–12‐week postpartum visit in women with HDP. However, the feasibility and practicality of postpartum cardiovascular surveillance are limited by disparities in access to echocardiography, resource allocation for prolonged follow‐up and challenges in improving patient engagement in postpartum care. © 2026 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.